[go: up one dir, main page]

AU2002218154A1 - Collectins as adjuvants - Google Patents

Collectins as adjuvants

Info

Publication number
AU2002218154A1
AU2002218154A1 AU2002218154A AU1815402A AU2002218154A1 AU 2002218154 A1 AU2002218154 A1 AU 2002218154A1 AU 2002218154 A AU2002218154 A AU 2002218154A AU 1815402 A AU1815402 A AU 1815402A AU 2002218154 A1 AU2002218154 A1 AU 2002218154A1
Authority
AU
Australia
Prior art keywords
collectins
adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218154A
Inventor
Jens Christian Jensenius
Anders Sjoholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002218154A1 publication Critical patent/AU2002218154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2002218154A 2000-11-27 2001-11-27 Collectins as adjuvants Abandoned AU2002218154A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001785 2000-11-27
DKPA200001785 2000-11-27
PCT/DK2001/000786 WO2002041913A1 (en) 2000-11-27 2001-11-27 Collectins as adjuvants

Publications (1)

Publication Number Publication Date
AU2002218154A1 true AU2002218154A1 (en) 2002-06-03

Family

ID=8159871

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218154A Abandoned AU2002218154A1 (en) 2000-11-27 2001-11-27 Collectins as adjuvants

Country Status (5)

Country Link
US (1) US20040043034A1 (en)
EP (1) EP1349573A1 (en)
CN (1) CN1487839A (en)
AU (1) AU2002218154A1 (en)
WO (1) WO2002041913A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018617A1 (en) * 2001-08-31 2003-03-06 Fuso Pharmaceutical Industries, Ltd. Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
BR0313650A (en) * 2002-08-20 2007-08-14 Genitrix Llc composition, expression vector, vaccine composition and use
US7491868B2 (en) * 2004-04-30 2009-02-17 The General Hospital Corporation Mannose binding lectin knock-out mice and methods of use thereof
US8067237B2 (en) 2005-12-13 2011-11-29 President And Fellows Of Harvard College Scaffolds for cell transplantation
JP5690143B2 (en) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Continuous cell programming device
WO2010074081A1 (en) 2008-12-22 2010-07-01 国立大学法人北海道大学 Protein substance having triple helix structure and manufacturing method therefor
EP3620185A1 (en) 2010-10-06 2020-03-11 President and Fellows of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
LT2838515T (en) 2012-04-16 2020-03-10 President And Fellows Of Harvard College Mesoporous silica compositions for modulating immune responses
EP3137105A4 (en) 2014-04-30 2017-12-27 President and Fellows of Harvard College Combination vaccine devices and methods of killing cancer cells
HK1247861A1 (en) 2015-01-30 2018-10-05 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
EP3280464A4 (en) 2015-04-10 2018-09-26 President and Fellows of Harvard College Immune cell trapping devices and methods for making and using the same
CN115487351A (en) 2016-02-06 2022-12-20 哈佛学院校长同事会 Remodel Blood Nest to rebuild immunity
EP3416679A4 (en) * 2016-02-16 2019-12-25 President and Fellows of Harvard College VACCINES AGAINST PATHOGENS AND METHODS OF PRODUCING AND USING THE SAME
FI3484448T3 (en) 2016-07-13 2025-06-16 Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
AU2017305345B2 (en) 2016-08-02 2024-09-05 President And Fellows Of Harvard College Biomaterials for modulating immune responses
CN107929728A (en) * 2017-04-19 2018-04-20 武汉博沃生物科技有限公司 A kind of pneumoprotein vaccine and preparation method thereof
WO2020061129A1 (en) 2018-09-19 2020-03-26 President And Fellows Of Harvard College Compositions and methods for labeling and modulation of cells in vitro and in vivo
WO2021222964A2 (en) * 2020-05-07 2021-11-11 Ess Holding Gmbh Immunogenic complexes and methods of producing and using the same
WO2022079308A1 (en) * 2020-10-16 2022-04-21 Institut Pasteur Chimeric constructs useful in vaccination and cancer therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224870B1 (en) * 1997-01-24 2001-05-01 Genitrix, Ltd. Vaccine compositions and methods of modulating immune responses
AU734196B2 (en) * 1996-03-28 2001-06-07 Whitehead Institute Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
EP0976403A1 (en) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvant comprising pulmonary surfactant
DK1181038T3 (en) * 1999-05-14 2004-08-09 Steffen Thiel New indications of mannan-binding lectin (MBL) for the treatment of immunocompromised individuals

Also Published As

Publication number Publication date
EP1349573A1 (en) 2003-10-08
US20040043034A1 (en) 2004-03-04
CN1487839A (en) 2004-04-07
WO2002041913A1 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2002221601A1 (en) Disinfectant
AU2001262847A1 (en) Language-understanding
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2002218154A1 (en) Collectins as adjuvants
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001259702A1 (en) Tissue regrafting
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002223503A1 (en) Decondenser unit
AU2001290931A1 (en) Ski-snowboard
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258924A1 (en) Microsatellite-aflp
AU2001254731A1 (en) Substituted phenyluracils
AU2001248840A1 (en) Novel collectins
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2002223604A1 (en) Substituted phenyluracils
AU2001262711A1 (en) Cytoprotectors
AU2001284173A1 (en) Calycins